Live from the NIH registry
Studies recruiting near Olympia right now
Top 25 of 234 recruiting studies, sorted by proximity — each links to its official registry page
CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms
Traumatic Brain Injury, Insomnia
N/A
Interventional 360 participants sought
Madigan Army Medical Center — Fort Lewis, Washington (14.8 mi)
· Sponsor: Johns Hopkins University
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Mary Bridge Children's Hospital and Health Center — Tacoma, Washington (25.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Tacoma, Washington (25.8 mi)
· Sponsor: AstraZeneca
Lay-Delivered Behavioral Activation in Senior Centers
Depression
N/A
Interventional 288 participants sought
Pt Defiance Senior Center — Tacoma, Washington (25.8 mi)
· Sponsor: University of Washington
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Providence Regional Cancer System-Lacey — Lacey, Washington (3.5 mi)
· Sponsor: SWOG Cancer Research Network
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Colitis, Ulcerative
N/A
Observational 300 participants sought
Washington Gastroenterology — Tacoma, Washington (25.8 mi)
· Sponsor: Pfizer
The Vanguard Study: Testing a New Way to Screen for Cancer
Bladder Carcinoma, Breast Carcinoma
N/A
Interventional 24,000 participants sought
Madigan Army Medical Center — Tacoma, Washington (25.8 mi)
· Sponsor: National Cancer Institute (NCI)
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
Northwest Medical Specialties, PLLC — Gig Harbor, Washington (24.8 mi)
· Sponsor: Pfizer
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Washington Gastroenterology - Tacoma — Tacoma, Washington (25.8 mi)
· Sponsor: Eli Lilly and Company
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Providence Regional Cancer System-Lacey — Lacey, Washington (3.5 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Vista Oncology Inc PS — Olympia, Washington (0.4 mi)
· Sponsor: Amgen
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Northwest Medical Specialties, PLLC ( Site 0093) — Tacoma, Washington (25.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
Adapting a Brief Suicide Intervention for Pediatric Primary Care: Enhancing Uptake and Impact
Suicide Prevention
N/A
Interventional 48 participants sought
Olympia Pediatrics — Olympia, Washington (0.4 mi)
· Sponsor: University of Washington
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Northwest Medical Specialties — Olympia, Washington (0.4 mi)
· Sponsor: American Society of Clinical Oncology
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
Mary Bridge Children's Hospital and Health Center — Tacoma, Washington (25.8 mi)
· Sponsor: National Cancer Institute (NCI)
Function After Anterior Cervical Discectomy and Fusion Surgery: Timing of Physical Therapy
Cervical Spine Degeneration, ACDF Surgery
N/A
Interventional 76 participants sought
Madigan Army Medical Center — Tacoma, Washington (25.8 mi)
· Sponsor: Vanderbilt University Medical Center
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
MultiCare Institute for Research & Innovation /ID# 255954 — Tacoma, Washington (25.8 mi)
· Sponsor: AbbVie
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Providence Regional Cancer System-Lacey — Lacey, Washington (3.5 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 3
Interventional 380 participants sought
Northwest Medical Specialties Tacoma /ID# 276281 — Tacoma, Washington (25.8 mi)
· Sponsor: AbbVie
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Ulcerative Colitis
Phase 2
Interventional 80 participants sought
Digestive Health Specialists — Tacoma, Washington (25.8 mi)
· Sponsor: Boehringer Ingelheim
Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial
Lung Carcinoma
N/A
Interventional 237 participants sought
South Puget Intertribal Planning Agency (SPIPA) — Shelton, Washington (15.4 mi)
· Sponsor: Fred Hutchinson Cancer Center
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
Providence Regional Cancer System-Lacey — Lacey, Washington (3.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Crohn Disease, Colitis, Ulcerative
Phase 3
Interventional 1,380 participants sought
Washington Gastroenterology - Tacoma ( Site 0295) — Tacoma, Washington (25.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Colitis Ulcerative
Phase 2
Interventional 204 participants sought
Washington Gastroenterology - Tacoma- Site Number : 8400009 — Tacoma, Washington (25.8 mi)
· Sponsor: Sanofi
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Olympia, Washington (0.4 mi)
· Sponsor: Medtronic